Intestinal immunoglobulin production after oral cholera vaccination in patients with IgA deficiency with or without IgG subclass deficiency.
Nilssen
D E
DE
Laboratory for Immunohistochemistry and Immunopathology (LIIPAT), University of Oslo, Rikshospitalet, Norway.
Friman
V
V
Theman
K
K
Björkander
J
J
Kilander
A
A
Holmgren
J
J
Hanson
L A
LA
Brandtzaeg
P
P
D000284:Administration, Oral; D000328:Adult; D001402:B-Lymphocytes / Q000276:immunology; D022121:Cholera Vaccines / Q000008:administration & dosage / Q000276:immunology*; D004386:Duodenum / Q000276:immunology; D005767:Gastrointestinal Diseases / Q000209:etiology / Q000517:prevention & control; D006801:Humans; D017098:IgA Deficiency / Q000150:complications / Q000276:immunology* / Q000628:therapy; D017099:IgG Deficiency / Q000150:complications / Q000276:immunology* / Q000628:therapy; D007074:Immunoglobulin G / Q000096:biosynthesis / Q000145:classification; D007136:Immunoglobulins / Q000096:biosynthesis; D007413:Intestinal Mucosa / Q000276:immunology*; D012141:Respiratory Tract Infections / Q000209:etiology / Q000517:prevention & control
D022121:Cholera Vaccines; D007074:Immunoglobulin G; D007136:Immunoglobulins